IGC Pharma (IGC) Short Interest Ratio & Short Volume

Short interest is the volume of IGC Pharma shares that have been sold short but have not yet been covered or closed out. As of August 15th, traders have sold 1,100,000 shares of IGC short. Learn More on IGC Pharma's current short interest.

IGC Pharma saw a decrease in short interest in August. As of August 15th, there was short interest totaling 1,100,000 shares, a decrease of 17.3% from the previous total of 1,330,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to IGC Pharma: Black Diamond Therapeutics, Inc. (12.12%), MEI Pharma, Inc. (40.00%), Greenwich LifeSciences, Inc. (17.35%), Milestone Pharmaceuticals Inc. (6.66%), Kyverna Therapeutics, Inc. (6.43%), Molecular Partners AG Sponsored ADR (0.08%), Eledon Pharmaceuticals, Inc. (9.12%), Ascend Wellness Holdings, Inc. (0.01%), Theratechnologies Inc. (0.83%), Nkarta, Inc. (12.21%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Lucid Group, Inc. ($8.00 billion), Spotify Technology ($5.48 billion), AppLovin Corporation ($5.11 billion), Reddit Inc. ($5.02 billion), Coinbase Global, Inc. ($3.99 billion), Charter Communications, Inc. ($3.89 billion), Live Nation Entertainment, Inc. ($3.18 billion), Seagate Technology Holdings PLC ($2.59 billion), ResMed Inc. ($2.55 billion), and Rocket Lab Corporation ($2.52 billion). View all of the most shorted stocks.

Short selling IGC is an investing strategy that aims to generate trading profit from IGC Pharma as its price is falling. IGC shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for IGC Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IGC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IGC, twice per month. The most recent reporting period available is August, 15 2025.